United States · Venture startup

Who invested in Spine BioPharma

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$14Mraised across 2 rounds since 2024, from 2 sources

$14MVenture$385KRound

Latest round: Round, $385KJun 2026
Biggest round: $14MVenture · Dec 2024
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026

$14MVenture$385KRound

First round: Venture, $14M
Biggest round: $14M
Between rounds: 18 months

The rounds

Jun 2026
Round$385K
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $385K sold, first sale Jun 2026
Dec 2024
Venture$14M2 new
- Vulcan Capital
- Cercano Management
Source recordedSEC filing: $14M sold, first sale Sept 2024

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2024Round2026

Vulcan CapitalCercano Management

Everyone who backed them

Vulcan CapitalFamily office1round

Cercano ManagementVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Spine BioPharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.